Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast-conserving therapy.

PURPOSE We reviewed our institution's experience treating patients with ductal carcinoma-in-situ (DCIS) with breast-conserving therapy (BCT) to determine the impact of patient age on outcome. PATIENTS AND METHODS From 1980 to 1993, 146 patients were treated with BCT for DCIS. All patients underwent excisional biopsy, and 64% underwent re-excision. All patients received whole-breast irradiation to a median dose of 45 Gy. Ninety-four percent of patients received a boost to the tumor bed, for a median total dose of 60.4 Gy. All slides on every patient were reviewed by one pathologist. The median follow-up period was 7.2 years. RESULTS Seventeen patients developed an ipsilateral local recurrence, for 5- and 10-year actuarial rates of 10.2% and 12.4%, respectively. The 10-year rate of ipsilateral failure was 26.1% in patients younger than 45 years of age versus 8.6% in older patients (P =.03). On multivariate analysis, young age was independently associated with recurrence of the index lesion (true recurrence/marginal miss ¿TR/MM failures), regardless of how it was analyzed (eg, < 45 years of age or as a continuous variable). In addition, young patients had a dramatically higher 10-year rate of invasive TR/MM failures (19.9% v 3.2%). In a separate multivariate analysis for the development of invasive TR/MM failures, only patient age and predominant nuclear grade were independently associated with recurrence. The relationship between excision volume and outcome was analyzed in the 95 patients who underwent re-excision. The 5-year actuarial rate of TR/MM failure was significantly worse only in young patients with smaller (< 40 mL) re-excision volumes (33.3% v 9.1%; P =.02). In a separate multivariate analysis of only these 95 patients (25 of whom were < 45 years of age), the volume of re-excision had the strongest association with outcome (P =.05). Patient age was no longer associated with local recurrence. CONCLUSION These findings suggest that young patients with DCIS have a significantly greater risk of local recurrence after BCT that is independent of other previously defined risk factors. Our data also suggest that the extent of resection may in part be related to the less optimal results that are observed in these patients.

[1]  D. Winchester,et al.  National treatment trends for ductal carcinoma in situ of the breast. , 1997, Archives of surgery.

[2]  F. Vicini,et al.  Ductal carcinoma in situ detected in the mammographic era: an analysis of clinical, pathologic, and treatment-related factors affecting outcome with breast-conserving therapy. , 1997, International journal of radiation oncology, biology, physics.

[3]  Anthony J. Guidi,et al.  Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history. , 1995, The cancer journal from Scientific American.

[4]  N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[5]  D. Cox Regression Models and Life-Tables , 1972 .

[6]  R. Fechner Ductal carcinoma involving the lobule of the breast: A source of confusion with lobular carcinoma in situ , 1971, Cancer.

[7]  D. Schultz,et al.  Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation. , 1996, The cancer journal from Scientific American.

[8]  S. Martino,et al.  Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  D. Schultz,et al.  Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  F. Vicini,et al.  Cancerization of lobules and atypical ductal hyperplasia adjacent to ductal carcinoma in situ of the breast. , 1998, American journal of clinical pathology.

[11]  David L. Page,et al.  Diagnostic Histopathology of the Breast , 1988 .

[12]  S J Schnitt,et al.  The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy. , 1991, Annals of surgery.

[13]  M. Silverstein,et al.  Intraductal carcinoma of the breast (208 cases): Clinical factors influencing treatment choice , 1990, Cancer.

[14]  Joseph Costantino,et al.  Pathologic findings from the national surgical adjuvant breast project (NSABP) protocol B‐17. Intraductal carcinoma (ductal carcinoma in situ) , 1995, Cancer.

[15]  C. Perez,et al.  Breast conservation therapy for intraductal carcinoma of the breast. , 1993, International journal of radiation oncology, biology, physics.

[16]  S. Schnitt,et al.  Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage. , 1985, International journal of radiation oncology, biology, physics.

[17]  J Costantino,et al.  Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight‐year update of Protocol B‐17 , 1999, Cancer.

[18]  S. Schnitt,et al.  Results of treating ductal carcinoma In situ of the breast with conservative surgery and radiation therapy , 1991, Cancer.

[19]  D. Neuberg,et al.  Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  B. McCormick,et al.  Duct carcinoma in situ of the breast: an analysis of local control after conservation surgery and radiotherapy. , 1991, International journal of radiation oncology, biology, physics.

[21]  J. Costantino,et al.  Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  F. Vicini,et al.  Outcome and prognostic factors for local recurrence in mammographically detected ductal carcinoma in situ of the breast treated with conservative surgery and radiation therapy. , 1995, International journal of radiation oncology, biology, physics.

[23]  K. Kerlikowske,et al.  Incidence of and treatment for ductal carcinoma in situ of the breast. , 1996, JAMA.

[24]  M. J. van de Vijver,et al.  Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. , 1998, International journal of radiation oncology, biology, physics.

[25]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[26]  A. Patchefsky,et al.  Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS). , 1997, International journal of radiation oncology, biology, physics.

[27]  D. Schultz,et al.  Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast‐conserving surgery and definitive irradiation correlation of pathologic parameters with outcome of treatment , 1993, Cancer.

[28]  N. Bundred,et al.  The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ. , 1998, British Journal of Cancer.

[29]  B Fisher,et al.  Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. , 1993, The New England journal of medicine.

[30]  D. Page,et al.  Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions , 1994, Cancer.